Literature DB >> 15990994

Treatment for HTLV-I associated arthropathy: a case study and synovial tissue culture analysis.

Toshiaki Takahashi1, Shigeki Takemoto, Katsuhito Kiyasu, Hiroshi Yamamoto, Toshikazu Tani, Isamu Miyoshi, Hirokuni Taguchi, Toshiaki Moriki, Emiko Miyazaki, Hideaki Enzan.   

Abstract

OBJECTIVE: There are few reports regarding the treatment of HTLV-I associated arthropathy (HAAP). This is a case study describing the treatment of a patient diagnosed with HAAP. We also analyzed the effects of various agents on cultured synovial tissue explants from the patient.
METHODS: Arthroscopic synovectomy of the left knee was performed. We investigated the effects of pirarubicin (THP), bestatin, betamethasone, and hyaluronic acid (HA) in synovial tissue culture to evaluate the efficacy of these medications.
RESULTS: Swelling and pain of the left knee was transiently diminished after synovectomy. However, bilateral swelling of the knees and C reactive protein (CRP) concentrations were increased. In the explant culture experiments, CD8+ cells decreased with the addition of bestatin, betamethasone, and HA. The structure of synovial cells was preserved by the addition of HA. However, the addition of THP induced fibrosis of synovial tissues, increased cells without nuclei, and diminished fascin-expressing cells.
CONCLUSION: THP inhibited, but HA preserved the structure of hypertrophic synovial cells. Scopic synovectomy effectively improved joint effusion and pain; however, the effect was transient, and additional treatment with predonisolone was required. Therefore, it is important to develop a more effective treatment for HAAP.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15990994     DOI: 10.1007/s00296-005-0604-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  18 in total

1.  Primary Sjögren's syndrome with antibodies to HTLV-I: clinical and laboratory features.

Authors:  K Eguchi; N Matsuoka; H Ida; M Nakashima; M Sakai; S Sakito; A Kawakami; K Terada; H Shimada; Y Kawabe
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

2.  Arthritis in patients infected with human T lymphotropic virus type I. Clinical and immunopathologic features.

Authors:  K Sato; I Maruyama; Y Maruyama; I Kitajima; Y Nakajima; M Higaki; K Yamamoto; N Miyasaka; M Osame; K Nishioka
Journal:  Arthritis Rheum       Date:  1991-06

3.  HTLV-I associated myelopathy, a new clinical entity.

Authors:  M Osame; K Usuku; S Izumo; N Ijichi; H Amitani; A Igata; M Matsumoto; M Tara
Journal:  Lancet       Date:  1986-05-03       Impact factor: 79.321

4.  Isolation of HTLV-I from cerebrospinal fluid of a patient with myelopathy.

Authors:  S Hirose; Y Uemura; M Fujishita; T Kitagawa; M Yamashita; J Imamura; Y Ohtsuki; H Taguchi; I Miyoshi
Journal:  Lancet       Date:  1986-08-16       Impact factor: 79.321

5.  Treatment of patients with polyarthritis and anti-HTLV-I antibodies with interferon-alpha.

Authors:  T Aoyagi; K Maeda; I Furuichi; K Eguchi; M Sakai; S Nagataki; K Iwasaki
Journal:  Ann Rheum Dis       Date:  1994-01       Impact factor: 19.103

Review 6.  Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis.

Authors:  W P Arend; J M Dayer
Journal:  Arthritis Rheum       Date:  1990-03

7.  Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease.

Authors:  M Yoshida; I Miyoshi; Y Hinuma
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

8.  Identification of human T cell leukemia virus in a Japanese patient with adult T cell leukemia and cutaneous lymphomatous vasculitis.

Authors:  B F Haynes; S E Miller; T J Palker; J O Moore; P H Dunn; D P Bolognesi; R S Metzgar
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

9.  Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells.

Authors:  T Uchiyama; T Hori; M Tsudo; Y Wano; H Umadome; S Tamori; J Yodoi; M Maeda; H Sawami; H Uchino
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

10.  Immunopathological mechanisms of human T cell lymphotropic virus type 1 (HTLV-I) uveitis. Detection of HTLV-I-infected T cells in the eye and their constitutive cytokine production.

Authors:  K Sagawa; M Mochizuki; K Masuoka; K Katagiri; T Katayama; T Maeda; A Tanimoto; S Sugita; T Watanabe; K Itoh
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.